Generation of Large Numbers of Myeloid Progenitors and Dendritic Cell Precursors from Murine Bone Marrow Using a Novel Cell Sorting Strategy
August 10th, 2018
8.9K views
Here we provide a method for identifying and isolating large numbers of GM-CSF driven myeloid cells using high speed cell sorting. Five distinct populations (Common myeloid progenitors, granulocyte/macrophage progenitors, monocytes, monocyte-derived macrophages, and monocyte-derived DCs) can be identified based on Ly6C and CD115 expression.
Overview
This article presents a method for isolating large populations of GM-CSF driven myeloid cells through high speed cell sorting. The technique allows for the identification of five distinct cell populations based on specific markers.
Key Study Components
Area of Science
- Immunology
- Cell Biology
- Developmental Biology
Background
- GM-CSF is crucial for myeloid cell development.
- Traditional methods yield low numbers of specific cell types.
- High speed cell sorting enhances cell isolation efficiency.
- Understanding myeloid cell populations is vital for immunological research.
Purpose of Study
- To provide a reliable method for isolating myeloid cells.
- To facilitate research in developmental immunology.
- To support therapeutic applications in bone marrow transplantation.
Methods Used
- High speed cell sorting based on Ly6C and CD115 expression.
- Preparation of mouse models for cell isolation.
- Use of specific markers to distinguish between cell populations.
- Protocol includes detailed steps for tissue preparation.
Main Results
- Identification of five distinct myeloid cell populations.
- Demonstrated efficiency in isolating low-abundance cells.
- Potential applications in therapeutic settings.
- Enhanced understanding of myeloid cell roles in immunity.
Conclusions
- The method significantly improves cell isolation capabilities.
- It opens new avenues for research in immunology.
- Future studies can leverage this technique for various applications.
Frequently Asked Questions
What are GM-CSF driven myeloid cells?
GM-CSF driven myeloid cells are immune cells that develop in response to Granulocyte-Macrophage Colony-Stimulating Factor, playing a key role in the immune response.
How does high speed cell sorting work?
High speed cell sorting uses specific markers to rapidly separate and isolate different cell populations based on their characteristics.
What are the implications of this research?
This research has implications for improving therapeutic strategies in bone marrow transplantation and enhancing our understanding of immune cell development.
What markers are used in this method?
The method utilizes Ly6C and CD115 expression to identify and isolate distinct myeloid cell populations.
Can this method be applied to other cell types?
While this method is focused on myeloid cells, similar techniques can be adapted for isolating other cell types based on different markers.
Executive Industry Relevance
This protocol enables reliable isolation of developmentally distinct myeloid progenitor and dendritic cell precursor populations from murine bone marrow cultures, supporting mechanistic studies of immune cell differentiation. By providing sufficient quantities of rare cell subsets, it facilitates functional assays and pathway analysis relevant to immunology target validation. The approach addresses a key bottleneck in preclinical immunology research where low yields limit downstream applications.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of myeloid lineage commitment and progenitor function through isolation of CMP, GMP, monocyte, moMac, and moDC subsets.
- Operational Value: Uses transient surface markers (Ly6C, CD115, CD11c, MHC-II) to define discrete developmental stages for hypothesis testing.
- Predictive Value: Supports mechanistic de-risking by linking surface phenotype to functional responses to pathogen-associated molecular patterns (PAMPs).
Screening & Assay Development
- Assay Readiness: Generates purified cell populations in sufficient numbers for downstream functional and developmental analyses.
- Reproducibility: Relies on standardized immunophenotyping and sorting strategy to ensure consistent isolation across experiments.
- Scalability: Enables production of large cell numbers from traditional low-yield ex vivo sources, supporting assay standardization.
Translational & Preclinical Research
- Disease Relevance: Provides a murine model system to study monocyte-derived dendritic cell and macrophage differentiation pathways.
- Translational Continuity: Isolated precursors allow functional comparison to inform preclinical models of innate immunity.
- Risk-Adjusted Advancement: Differential PAMP responses across subsets enable mechanistic insight into immune activation thresholds.
Pipeline & Workflow Integration
The method fits within the discovery biology phase, enabling isolation of myeloid progenitors prior to functional screening or mechanistic follow-up in immunology-focused programs.
- Discovery Biology: Supports hypothesis testing on myeloid differentiation pathways by providing purified progenitor and precursor populations.
- Screening: Generates standardized cell inputs for assay development targeting innate immune responses.
- Analytics: Enables quantitative comparison of subset-specific responses to stimuli such as PAMPs.
- Translational Research: Connects ex vivo isolation to functional validation in disease-relevant immune contexts.
- Enterprise Reuse: Establishes a reproducible immunophenotyping and sorting workflow applicable across murine myeloid studies.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in myeloid development by enabling isolation of transient progenitor stages.
- Operational Value: Standardizes isolation of low-abundance cells using defined surface marker panels.
- Strategic Value: Improves confidence in target validation by linking phenotype to function in immune cell subsets.
- Portfolio Impact: Supports risk-adjusted prioritization of immunomodulatory targets through mechanistic de-risking.
Implementation Considerations
- Requires expertise in murine bone marrow harvest and flow cytometry-based cell sorting.
- Dependent on access to high-speed cell sorter and fluorochrome-conjugated antibodies against Ly6C, CD115, CD11c, and MHC-II.
- Necessitates standardization of GM-CSF culture duration to enrich desired progenitor or precursor populations.
- Involves optimization of viability gating to exclude dead cells and ensure functional integrity of sorted subsets.
- Limited to murine systems; adaptation to human models would require validation of equivalent surface markers.
Biopharma FAQs
Why does isolating Ly6C and CD115-defined populations matter for target validation?
Isolating cells based on Ly6C and CD115 expression enables discrimination of myeloid progenitors at distinct developmental stages, which is critical for validating targets involved in lineage commitment. This approach supports mechanistic de-risking by linking surface phenotype to functional identity in GM-CSF-driven cultures.
How does isolating CMP and GMP subsets support early discovery pipeline goals?
Isolating common myeloid progenitors (CMP) and granulocyte/macrophage progenitors (GMP) provides access to early hematopoietic precursors, enabling interrogation of multipotency and lineage bias. This supports target validation by allowing functional assessment of progenitors before commitment to monocyte or granulocyte fates.
What quantitative measurements does CD11c expression enable within the Ly6C-negative, CD115-negative gate?
CD11c expression distinguishes monocyte-derived dendritic cell precursors (moDC) from common myeloid progenitors (CMP) within the Ly6C−, CD115− population, enabling quantitative separation of dendritic cell-committed cells. This measurement supports functional assays comparing antigen-presenting capacity between subsets.
Why are replication requirements important for cross-functional collaboration in myeloid subset studies?
Replication ensures consistent isolation of developmentally defined subsets across experiments, which is essential for comparing functional responses such as PAMP stimulation between labs. Standardized sorting based on transient markers reduces variability in downstream immunological assays.
What statistical analysis capabilities are required before implementing this sorting strategy in discovery workflows?
Implementation requires gating strategy validation, including viability exclusion and compensation controls, to ensure accurate subset identification. Statistical confidence in subset purity and yield supports reliable functional readouts and comparative analysis across conditions.
